Understanding interactions of gastric inhibitory polypeptide (GIP) with its G-protein coupled receptor through NMR and molecular modeling
- PMID: 17437246
- DOI: 10.1002/psc.839
Understanding interactions of gastric inhibitory polypeptide (GIP) with its G-protein coupled receptor through NMR and molecular modeling
Abstract
Gastric inhibitory polypeptide (GIP, or glucose-dependent insulinotropic polypeptide) is a 42-amino acid incretin hormone moderating glucose-induced insulin secretion. Antidiabetic therapy based on GIP holds great promise because of the fact that its insulinotropic action is highly dependent on the level of glucose, overcoming the sideeffects of hypoglycemia associated with the current therapy of Type 2 diabetes. The truncated peptide, GIP(1-30)NH2, has the same activity as the full length native peptide. We have studied the structure of GIP(1-30)NH2 and built a model of its G-protein coupled receptor (GPCR). The structure of GIP(1-30)NH2 in DMSO-d6 and H2O has been studied using 2D NMR (total correlation spectroscopy (TOCSY), nuclear overhauser effect spectroscopy (NOESY), double quantum filtered-COSY (DQF-COSY), 13C-heteronuclear single quantum correlation (HSQC) experiments, and its conformation built by MD simulations with the NMR data as constraints. The peptide in DMSO-d6 exhibits an alpha-helix between residues Ile12 and Lys30 with a discontinuity at residues Gln19 and Gln20. In H2O, the alpha-helix starts at Ile7, breaks off at Gln19, and then continues right through to Lys30. GIP(1-30)NH2 has all the structural features of peptides belonging to family B1 GPCRs, which are characterized by a coil at the N-terminal and a long C-terminal alpha-helix with or without a break. A model of the seven transmembrane (TM) helices of the GIP receptor (GIPR) has been built on the principles of comparative protein modeling, using the crystal structure of bovine rhodopsin as a template. The N-terminal domain of GIPR has been constructed from the NMR structure of the N-terminal of corticoptropin releasing factor receptor (CRFR), a family B1 GCPR. The intra and extra cellular loops and the C-terminal have been modeled from fragments retrieved from the PDB. On the basis of the experimental data available for some members of family B1 GPCRs, four pairs of constraints between GIP(1-30)NH2 and its receptor were used in the FTDOCK program, to build the complete model of the GIP(1-30)NH2:GIPR complex. The model can rationalize the various experimental observations including the potency of the truncated GIP peptide. This work is the first complete model at the atomic level of GIP(1-30)NH2 and of the complex with its GPCR.
Copyright (c) 2007 European Peptide Society and John Wiley & Sons, Ltd.
Similar articles
-
Mapping interactions of gastric inhibitory polypeptide with GIPR N-terminus using NMR and molecular dynamics simulations.J Pept Sci. 2010 Aug;16(8):383-91. doi: 10.1002/psc.1250. J Pept Sci. 2010. PMID: 20607844
-
Conformational, receptor interaction and alanine scan studies of glucose-dependent insulinotropic polypeptide.Biochim Biophys Acta. 2011 Jul;1814(7):882-8. doi: 10.1016/j.bbapap.2011.04.002. Epub 2011 Apr 27. Biochim Biophys Acta. 2011. PMID: 21539943
-
Structural and pharmacological characterization of novel potent and selective monoclonal antibody antagonists of glucose-dependent insulinotropic polypeptide receptor.J Biol Chem. 2013 Jul 5;288(27):19760-72. doi: 10.1074/jbc.M112.426288. Epub 2013 May 20. J Biol Chem. 2013. PMID: 23689510 Free PMC article.
-
Glucose-dependent insulinotropic polypeptide (GIP) receptor antagonists as anti-diabetic agents.Peptides. 2018 Feb;100:173-181. doi: 10.1016/j.peptides.2017.11.021. Peptides. 2018. PMID: 29412817 Review.
-
Molecular interactions of full-length and truncated GIP peptides with the GIP receptor - A comprehensive review.Peptides. 2020 Mar;125:170224. doi: 10.1016/j.peptides.2019.170224. Epub 2019 Dec 3. Peptides. 2020. PMID: 31809770 Review.
Cited by
-
N-terminally and C-terminally truncated forms of glucose-dependent insulinotropic polypeptide are high-affinity competitive antagonists of the human GIP receptor.Br J Pharmacol. 2016 Mar;173(5):826-38. doi: 10.1111/bph.13384. Epub 2016 Jan 30. Br J Pharmacol. 2016. PMID: 26572091 Free PMC article.
-
Species-specific action of (Pro3)GIP - a full agonist at human GIP receptors, but a partial agonist and competitive antagonist at rat and mouse GIP receptors.Br J Pharmacol. 2016 Jan;173(1):27-38. doi: 10.1111/bph.13323. Epub 2015 Nov 20. Br J Pharmacol. 2016. PMID: 26359804 Free PMC article.
-
The Location of Missense Variants in the Human GIP Gene Is Indicative for Natural Selection.Front Endocrinol (Lausanne). 2022 Jun 29;13:891586. doi: 10.3389/fendo.2022.891586. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35846282 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources